Avricore Health (AVCRF) Long-Term Deferred Tax (2020 - 2025)

Avricore Health has disclosed Long-Term Deferred Tax across 5 years of filings, most recently posting -$5.0 million for Q4 2025.

• In Q4 2025, Long-Term Deferred Tax fell 7.33% year-over-year to -$5.0 million; the TTM figure through Dec 2025 stood at -$5.0 million (down 7.33% YoY), while the FY2025 annual figure was -$4.9 million, down 4.99% from the prior year.
• Long-Term Deferred Tax declined to -$5.0 million in Q4 2025, from -$4.6 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for AVCRF reached as high as -$4.5 million in Q4 2023 and fell as low as -$5.0 million in Q4 2025.
• The 4-year median for Long-Term Deferred Tax is -$4.7 million (2021), against an average of -$4.7 million.
• Annual changes were most pronounced in 2021 — Long-Term Deferred Tax dropped 9.97% — and 2024, when it dropped 1.85%.
• A 4-year view of Long-Term Deferred Tax shows it stood at -$4.7 million in 2021, then advanced by 4.53% to -$4.5 million in 2023, then slipped by 1.85% to -$4.6 million in 2024, then decreased by 7.33% to -$5.0 million in 2025.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered -$5.0 million, -$4.6 million, and -$4.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.